These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16626414)

  • 1. A primer on dynamic optimization and optimal control in pharmacoeconomics.
    Vernon JA; Hughen WK
    Value Health; 2006; 9(2):106-13. PubMed ID: 16626414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health economics of the treatment of hyperlipidemia and hypertension.
    McMurray J
    Am J Hypertens; 1999 Oct; 12(10 Pt 2):99S-104S. PubMed ID: 10555609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis.
    Brandeau ML; Zaric GS; Richter A
    J Health Econ; 2003 Jul; 22(4):575-98. PubMed ID: 12842316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics: state of the art in 1997.
    Schulman KA; Linas BP
    Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations.
    Hughes D; Cowell W; Koncz T; Cramer J;
    Value Health; 2007; 10(6):498-509. PubMed ID: 17970932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providing cost-effective therapy using pharmacoeconomic evaluations: the public sector approach.
    Finder S
    Clin Ther; 1997; 19(1):160-6. PubMed ID: 9182021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
    Reeder CE
    Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S5-8. PubMed ID: 8846244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of treating mental illness from a managed care perspective.
    Docherty JP
    J Clin Psychiatry; 1999; 60 Suppl 3():49-52; discussion 53. PubMed ID: 10073378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomics--an aid to better decision-making.
    Arenas-Guzman R; Tosti A; Hay R; Haneke E;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():34-9. PubMed ID: 16120204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Introduction to the theory of pharmaco-economics].
    Kurz X; Dresse A
    Rev Med Liege; 1998 May; 53(5):230-5. PubMed ID: 9689873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget impact analysis.
    Leelahavarong P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S65-71. PubMed ID: 24964701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinician's perspective on pharmacoeconomics and rheumatology.
    Thielscher C
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S91-5. PubMed ID: 23078957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics and managed care: methodologic and policy issues.
    Luce BR
    Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacoeconomics and cost of cancer drugs].
    Camps Herrero C; Caballero Díaz C; Blasco Cordellat A
    Farm Hosp; 2010 Mar; 34 Suppl 1():12-5. PubMed ID: 20920852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics: an emerging discipline.
    Letizia C
    Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for performing a pharmacoeconomic analysis.
    Jolicoeur LM; Jones-Grizzle AJ; Boyer JG
    Am J Hosp Pharm; 1992 Jul; 49(7):1741-7. PubMed ID: 1621734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.